{
    "hands_on_practices": [
        {
            "introduction": "The cornerstone of effective perinatal psychiatric care is precise diagnosis and risk assessment, particularly in high-stakes situations where clinical presentations can overlap. This exercise challenges you to differentiate ego-dystonic intrusive thoughts, characteristic of postpartum Obsessive-Compulsive Disorder (OCD), from the delusions and impaired insight of postpartum psychosis. Mastering this distinction is critical for implementing a proportionate, evidence-based management plan that ensures the safety of both mother and infant while avoiding the iatrogenic harm of unnecessary interventions or family separation .",
            "id": "4738443",
            "problem": "A clinician is evaluating a postpartum patient for distressing thoughts about infant harm. The foundational definitions relevant to this evaluation are as follows: according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), obsessions in Obsessive-Compulsive Disorder (OCD) are recurrent and persistent thoughts, urges, or images that are experienced as unwanted and intrusive (ego-dystonic), cause marked anxiety or distress, and are typically associated with attempts to ignore or neutralize them; psychosis is characterized by delusions and/or hallucinations, impaired reality testing, and lack of insight (ego-syntonic or not recognized as aberrant). In risk assessment, elevated near-term risk of harmful action emerges from the convergence of intent, plan, access to means, and reduced insight, whereas intact insight, high distress at the thought, avoidance behaviors, and the absence of intent reduce near-term risk. Empirically, postpartum OCD is relatively common (approximately 3%–5%), whereas postpartum psychosis is rarer (approximately 1–2 per 1000 births), but carries high risk when present.\n\nCase: A 31-year-old primiparous woman at 12 days postpartum presents with vivid images of stabbing her infant that “pop into her head.” She reports these images are horrifying and unwanted, she immediately removes herself from the kitchen, hides knives, seeks reassurance from her partner, and avoids being alone with the infant during diaper changes. She spends about 2 hours per day checking locks and re-reading safety guidelines. She denies any intent or desire to harm, has no plan, and says, “I know these are my own thoughts but they feel like a nightmare I do not want.” She has preserved insight and recognizes the thoughts as irrational. She denies auditory hallucinations, denies beliefs that the infant is possessed or evil, and shows no disorganization, no decreased need for sleep beyond newborn-related sleep fragmentation, and no elevated mood or racing thoughts. Past psychiatric history is notable for Obsessive-Compulsive Disorder (OCD) in adolescence without psychosis. Her partner is supportive and available most evenings. There is no substance use. Vital signs are unremarkable. She reports shame and is afraid that disclosing these thoughts will lead to Child Protective Services (CPS) involvement. She seeks help to reduce the distress and to safely care for her infant.\n\nQuestion: Which option most accurately differentiates the clinical phenomenon and outlines a proportionate, ethics-informed risk assessment and management plan that minimizes unnecessary CPS involvement while ensuring safety?\n\nA. Classify the presentation as postpartum psychosis and initiate immediate involuntary hospitalization with antipsychotic treatment. Notify CPS to arrange infant removal from the home until the mother is stabilized. Prohibit unsupervised maternal contact.\n\nB. Classify the presentation as severe postpartum depression with psychotic features because the content involves infant harm. Begin antipsychotic and mood stabilizer, notify CPS, and arrange continuous nursing observation of mother-infant interactions on an inpatient unit.\n\nC. Classify the presentation as postpartum OCD with ego-dystonic intrusive images and intact insight. Conduct a structured risk assessment focusing on absence of intent or plan, presence of insight, avoidance/neutralization behaviors, and supportive supervision. Initiate evidence-based outpatient care with Exposure and Response Prevention (ERP) and a Selective Serotonin Reuptake Inhibitor (SSRI), co-create a time-limited, proportionate safety plan (for example, supervised care during peak distress tasks, staged reduction of safety behaviors within therapy, and an emergency contact plan), and do not notify CPS in the absence of intent, plan, or psychotic features. Escalate the setting only if insight diminishes or intent emerges.\n\nD. Classify the presentation as generalized anxiety disorder because there is no intent. Offer reassurance, advise the patient to ignore the thoughts, avoid formal risk assessment to prevent iatrogenic anxiety, and do not initiate psychotherapy or medication. Avoid any safety planning because it may reinforce anxiety.",
            "solution": "The problem statement is first validated against the specified criteria.\n\n### Step 1: Extract Givens\n**Definitions and Principles:**\n1.  **Obsessions (in OCD)**: Recurrent and persistent thoughts, urges, or images that are experienced as unwanted and intrusive (ego-dystonic), cause marked anxiety or distress, and are typically associated with attempts to ignore or neutralize them. Source: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).\n2.  **Psychosis**: Characterized by delusions and/or hallucinations, impaired reality testing, and lack of insight (ego-syntonic or not recognized as aberrant).\n3.  **Elevated near-term risk of harmful action**: Emerges from the convergence of intent, plan, access to means, and reduced insight.\n4.  **Reduced near-term risk**: Associated with intact insight, high distress at the thought, avoidance behaviors, and the absence of intent.\n5.  **Prevalence of Postpartum OCD**: Approximately 3%–5%.\n6.  **Prevalence of Postpartum Psychosis**: Approximately 1–2 per 1000 births.\n\n**Case Data:**\n1.  **Patient**: 31-year-old primiparous woman.\n2.  **Timing**: 12 days postpartum.\n3.  **Presenting Symptom**: Vivid images of stabbing her infant that \"pop into her head.\"\n4.  **Patient's Reaction to Thoughts**: Describes them as \"horrifying and unwanted.\" States, \"I know these are my own thoughts but they feel like a nightmare I do not want.\" Recognizes the thoughts as irrational. Experiences shame and fear of CPS involvement.\n5.  **Behaviors (Compulsions/Neutralizing Acts)**: Immediately removes herself from the kitchen, hides knives, seeks reassurance from her partner, avoids being alone with the infant during diaper changes. Spends about 2 hours per day checking locks and re-reading safety guidelines.\n6.  **Risk Assessment Factors**: Denies any intent or desire to harm. Has no plan.\n7.  **Insight**: Preserved insight.\n8.  **Psychosis Screen (Negative)**: Denies auditory hallucinations, denies beliefs that the infant is possessed or evil, shows no disorganization, no decreased need for sleep (beyond newborn-related fragmentation), and no elevated mood or racing thoughts.\n9.  **History**: Past psychiatric history of Obsessive-Compulsive Disorder (OCD) in adolescence without psychosis. No substance use.\n10. **Social Support**: Partner is supportive and available most evenings.\n11. **Clinical Status**: Vital signs are unremarkable.\n12. **Goal**: Seeks help to reduce distress and safely care for her infant.\n\n### Step 2: Validate Using Extracted Givens\nThe problem statement is evaluated as follows:\n- **Scientifically Grounded**: The problem is firmly grounded in clinical psychiatry. The definitions for obsession and psychosis are explicitly and correctly cited from the DSM-5. The prevalence statistics for postpartum OCD and postpartum psychosis are consistent with established epidemiological data. The principles of risk assessment provided are standard in clinical practice. The case vignette is a classic and realistic presentation of perinatal OCD.\n- **Well-Posed**: The problem is well-posed. It provides a detailed set of symptoms and historical data and asks for the most accurate classification and corresponding management plan from a set of discrete options. A unique, best-fit solution can be determined through logical application of the provided definitions.\n- **Objective**: The language is clinical, descriptive, and free of subjective bias. It presents a factual scenario for analysis.\n\nThe problem does not exhibit any flaws such as scientific unsoundness, incompleteness, contradiction, or ambiguity. It is a valid, formalizable problem in clinical reasoning.\n\n### Step 3: Verdict and Action\nThe problem is **valid**. Proceeding to the solution.\n\n### Derivation of Solution\n\n1.  **Differential Diagnosis**: The primary task is to differentiate between postpartum OCD, postpartum psychosis, and other perinatal mood/anxiety disorders.\n    -   **Applying the definition of Obsession**: The patient's symptoms align perfectly with the provided definition. She has recurrent (\"pop into her head\"), intrusive images of harm (\"stabbing her infant\"). They are experienced as unwanted and distressing (\"horrifying and unwanted,\" \"nightmare I do not want\"), classifying them as ego-dystonic. She engages in behaviors to ignore or neutralize them (hiding knives, seeking reassurance, avoiding being alone with the infant, checking behaviors), which are compulsions. This clinical picture is pathognomonic for OCD. The history of adolescent OCD further supports this diagnosis.\n    -   **Applying the definition of Psychosis**: The patient's presentation is inconsistent with psychosis. She has no delusions (e.g., fixed false beliefs about the infant being evil) and no hallucinations. Most critically, she has intact reality testing and preserved insight (\"I know these are my own thoughts but they feel like a nightmare,\" recognizes them as \"irrational\"). Her thoughts are ego-dystonic, contrasting with the typical ego-syntonic or insight-lacking nature of psychotic symptoms.\n    -   **Other diagnoses**: While postpartum depression is common, the patient does not report core depressive symptoms like pervasive low mood or anhedonia. Generalized anxiety disorder involves diffuse worry, whereas this patient's symptoms are focused, intrusive images with related compulsions, the hallmark of OCD.\n\n2.  **Risk Assessment**: The next step is to evaluate the near-term risk of harm.\n    -   The problem provides a framework: risk is elevated by intent, plan, and reduced insight. Risk is reduced by lack of intent, lack of plan, intact insight, high distress, and avoidance behaviors.\n    -   The patient explicitly \"denies any intent or desire to harm\" and \"has no plan.\"\n    -   Her insight is \"preserved.\"\n    -   She experiences high distress (\"horrifying\") and engages in multiple avoidance/protective behaviors (hiding knives, etc.).\n    -   Therefore, according to the provided framework, the near-term risk of the patient acting on these thoughts is low. Her ego-dystonic thoughts and protective actions demonstrate a desire to keep the infant safe, which is the opposite of intent to harm.\n\n3.  **Management Plan**: The management plan must be proportionate to the diagnosis and risk level.\n    -   **Diagnosis**: Postpartum OCD.\n    -   **Risk Level**: Low.\n    -   **Treatment**: The evidence-based, first-line treatments for OCD are pharmacotherapy with a Selective Serotonin Reuptake Inhibitor (SSRI) and a specific form of cognitive-behavioral therapy called Exposure and Response Prevention (ERP).\n    -   **Safety and Ethics**: Given the low risk and the patient's protective stance, involuntary hospitalization or separation from the infant are not indicated. Such actions would be iatrogenic, causing significant trauma, undermining the therapeutic alliance, and potentially worsening the patient's condition. Notifying Child Protective Services (CPS) is not warranted in the absence of evidence of abuse or neglect; the mother's presentation is one of seeking help to *prevent* harm, not an indicator of intent to harm. A collaborative, proportionate safety plan (e.g., ensuring the supportive partner is present during high-stress times) is appropriate to manage the patient's acute distress while treatment is initiated. The goal is to support the mother-infant dyad, not disrupt it.\n\n### Evaluation of Options\n\n**A. Classify the presentation as postpartum psychosis and initiate immediate involuntary hospitalization with antipsychotic treatment. Notify CPS to arrange infant removal from the home until the mother is stabilized. Prohibit unsupervised maternal contact.**\n-   **Evaluation**: This option misclassifies the condition as psychosis, ignoring the clear evidence for OCD (ego-dystonic thoughts, compulsions, intact insight) and the absence of psychotic symptoms. The proposed management is extremely aggressive, medically unnecessary, ethically inappropriate, and potentially harmful. It contradicts the low-risk assessment.\n-   **Verdict**: **Incorrect**.\n\n**B. Classify the presentation as severe postpartum depression with psychotic features because the content involves infant harm. Begin antipsychotic and mood stabilizer, notify CPS, and arrange continuous nursing observation of mother-infant interactions on an inpatient unit.**\n-   **Evaluation**: This option also misclassifies the condition. The thoughts are obsessional, not psychotic, as established by the patient's intact insight and ego-dystonic experience. The primary diagnosis is not depression based on the provided symptoms. The management plan is based on this misdiagnosis and is therefore inappropriate and overly restrictive.\n-   **Verdict**: **Incorrect**.\n\n**C. Classify the presentation as postpartum OCD with ego-dystonic intrusive images and intact insight. Conduct a structured risk assessment focusing on absence of intent or plan, presence of insight, avoidance/neutralization behaviors, and supportive supervision. Initiate evidence-based outpatient care with Exposure and Response Prevention (ERP) and a Selective Serotonin Reuptake Inhibitor (SSRI), co-create a time-limited, proportionate safety plan (for example, supervised care during peak distress tasks, staged reduction of safety behaviors within therapy, and an emergency contact plan), and do not notify CPS in the absence of intent, plan, or psychotic features. Escalate the setting only if insight diminishes or intent emerges.**\n-   **Evaluation**: This option provides the correct diagnosis (postpartum OCD) and accurately describes the key features (ego-dystonic, intact insight). It outlines a clinically sound risk assessment that directly applies the principles given in the problem statement. The proposed management plan includes the gold-standard outpatient treatments (ERP and SSRI), a proportionate and collaborative safety plan, and the ethically correct decision regarding CPS notification. It appropriately defines the threshold for escalation of care. This approach is effective, safe, and ethical.\n-   **Verdict**: **Correct**.\n\n**D. Classify the presentation as generalized anxiety disorder because there is no intent. Offer reassurance, advise the patient to ignore the thoughts, avoid formal risk assessment to prevent iatrogenic anxiety, and do not initiate psychotherapy or medication. Avoid any safety planning because it may reinforce anxiety.**\n-   **Evaluation**: This option misclassifies the condition as generalized anxiety disorder, missing the specific structure of obsessions and compulsions. The management advice is substandard and negligent. Advising an OCD patient to \"ignore the thoughts\" is futile and counter-therapeutic. Avoiding a formal risk assessment is a breach of clinical duty. Withholding evidence-based treatment (psychotherapy or medication) is malpractice. While some safety behaviors can be maladaptive, a complete avoidance of safety planning is reckless in the acute phase; therapeutic safety planning is a standard component of care.\n-   **Verdict**: **Incorrect**.",
            "answer": "$$\\boxed{C}$$"
        },
        {
            "introduction": "Effective psychopharmacology during pregnancy requires an understanding that a patient's physiology is not static. Significant changes in metabolism and drug clearance can alter steady-state drug concentrations, potentially leading to a loss of efficacy. This practice will guide you through the first principles of pharmacokinetics to quantify how an increase in drug clearance impacts therapeutic levels and to determine the necessary dose adjustment . This skill is essential for proactively managing medication to maintain maternal mental health throughout gestation.",
            "id": "4738446",
            "problem": "A pregnant patient with major depressive disorder and comorbid generalized anxiety disorder is being treated with a selective serotonin reuptake inhibitor (SSRI). Before pregnancy, the patient was stable on a once-daily dose of $D_{0}$, with oral bioavailability $F_{0}$ and apparent clearance $CL_{0}$. During the third trimester, physiologic changes increase the drug’s clearance to $CL_{1} = \\alpha \\, CL_{0}$ with $\\alpha = 1.5$, while oral bioavailability remains $F_{1} = F_{0}$. Assume linear pharmacokinetics, steady-state conditions, a fixed dosing interval, and no change in protein binding such that total concentration tracks efficacy in this patient.\n\nUsing the steady-state principle that, for linear pharmacokinetics with a constant dosing interval, the average steady-state concentration is proportional to the product of bioavailability and dose divided by clearance, derive from first principles:\n\n1) The ratio $r$ of the new steady-state average concentration during pregnancy to the pre-pregnancy steady-state average concentration if the dose is not changed (i.e., $D_{1} = D_{0}$).\n\n2) The multiplicative dose-adjustment factor $\\beta$ such that choosing $D_{1} = \\beta \\, D_{0}$ during pregnancy restores the pre-pregnancy steady-state average concentration.\n\nExpress $r$ and $\\beta$ as exact fractions. Provide both values as two dimensionless quantities. No rounding is required, and no units are needed in your final answer.",
            "solution": "The problem requires the derivation of two quantities related to pharmacokinetic changes during pregnancy: the ratio of steady-state concentrations if the dose is held constant, and the dose-adjustment factor needed to maintain the original concentration. The analysis is based on the principle of linear pharmacokinetics at a steady state.\n\nThe fundamental relationship provided is that the average steady-state concentration, $C_{ss,avg}$, is proportional to the product of oral bioavailability ($F$) and dose ($D$), divided by apparent clearance ($CL$). This can be written as:\n$$ C_{ss,avg} = K \\frac{F \\cdot D}{CL} $$\nwhere $K$ is a constant of proportionality. Since the dosing interval is fixed, $K$ remains constant throughout the analysis.\n\nLet the subscript $0$ denote the pre-pregnancy state and the subscript $1$ denote the third-trimester pregnancy state.\n\nThe givens are:\nPre-pregnancy dose: $D_{0}$\nPre-pregnancy bioavailability: $F_{0}$\nPre-pregnancy clearance: $CL_{0}$\n\nThird-trimester bioavailability: $F_{1} = F_{0}$\nThird-trimester clearance: $CL_{1} = \\alpha \\cdot CL_{0}$, with $\\alpha = 1.5$. We express $\\alpha$ as an exact fraction: $\\alpha = \\frac{3}{2}$.\n\nThe average steady-state concentration before pregnancy is:\n$$ C_{ss,avg,0} = K \\frac{F_{0} \\cdot D_{0}}{CL_{0}} $$\n\nThe average steady-state concentration during the third trimester is a function of the third-trimester dose $D_{1}$:\n$$ C_{ss,avg,1} = K \\frac{F_{1} \\cdot D_{1}}{CL_{1}} $$\n\nSubstituting the given relationships for $F_{1}$ and $CL_{1}$:\n$$ C_{ss,avg,1} = K \\frac{F_{0} \\cdot D_{1}}{(\\alpha \\cdot CL_{0})} $$\n\n1) Calculation of the concentration ratio $r$:\nThe first task is to find the ratio $r = \\frac{C_{ss,avg,1}}{C_{ss,avg,0}}$ under the condition that the dose is not changed, i.e., $D_{1} = D_{0}$.\n\nWe form the ratio using the expressions for $C_{ss,avg,0}$ and $C_{ss,avg,1}$:\n$$ r = \\frac{C_{ss,avg,1}}{C_{ss,avg,0}} = \\frac{K \\frac{F_{0} \\cdot D_{1}}{(\\alpha \\cdot CL_{0})}}{K \\frac{F_{0} \\cdot D_{0}}{CL_{0}}} $$\nSetting $D_{1} = D_{0}$ gives:\n$$ r = \\frac{K \\frac{F_{0} \\cdot D_{0}}{(\\alpha \\cdot CL_{0})}}{K \\frac{F_{0} \\cdot D_{0}}{CL_{0}}} $$\nThe terms $K$, $F_{0}$, $D_{0}$, and $CL_{0}$ are non-zero and cancel out, leaving:\n$$ r = \\frac{1}{\\alpha} $$\nSubstituting the value $\\alpha = \\frac{3}{2}$:\n$$ r = \\frac{1}{\\frac{3}{2}} = \\frac{2}{3} $$\n\n2) Calculation of the dose-adjustment factor $\\beta$:\nThe second task is to find the multiplicative factor $\\beta$ such that a new dose $D_{1} = \\beta \\cdot D_{0}$ restores the pre-pregnancy steady-state concentration, i.e., $C_{ss,avg,1} = C_{ss,avg,0}$.\n\nWe set the expressions for the two concentrations equal:\n$$ K \\frac{F_{1} \\cdot D_{1}}{CL_{1}} = K \\frac{F_{0} \\cdot D_{0}}{CL_{0}} $$\nSubstitute the relationships $F_{1} = F_{0}$, $CL_{1} = \\alpha \\cdot CL_{0}$, and the new dose definition $D_{1} = \\beta \\cdot D_{0}$:\n$$ K \\frac{F_{0} \\cdot (\\beta \\cdot D_{0})}{(\\alpha \\cdot CL_{0})} = K \\frac{F_{0} \\cdot D_{0}}{CL_{0}} $$\nThe non-zero terms $K$, $F_{0}$, $D_{0}$, and $CL_{0}$ cancel from both sides of the equation:\n$$ \\frac{\\beta}{\\alpha} = 1 $$\nSolving for $\\beta$, we find:\n$$ \\beta = \\alpha $$\nSubstituting the value $\\alpha = \\frac{3}{2}$:\n$$ \\beta = \\frac{3}{2} $$\n\nThe two dimensionless quantities are the ratio $r = \\frac{2}{3}$ and the dose-adjustment factor $\\beta = \\frac{3}{2}$.",
            "answer": "$$\\boxed{\\begin{pmatrix} \\frac{2}{3} & \\frac{3}{2} \\end{pmatrix}}$$"
        },
        {
            "introduction": "Following delivery, a primary concern for medicated patients is the safety of breastfeeding. Shared decision-making in this context must be grounded in a quantitative assessment of infant exposure, not just broad generalizations. This exercise provides hands-on practice in calculating the Relative Infant Dose (RID), the gold-standard metric used to evaluate the level of a medication transferred through breast milk . By computing the RID, you can translate pharmacological data into a clinically meaningful value that directly informs discussions about the risks and benefits of breastfeeding while on medication.",
            "id": "4738487",
            "problem": "In perinatal psychopharmacology, clinicians often rely on the concept of relative infant dose (RID) to evaluate the exposure of a breastfed infant to a maternal medication used for mood or anxiety disorders. Relative infant dose (RID) is conceptually defined as the proportion of the infant’s daily dose obtained through breast milk, normalized to infant body weight, relative to the maternal daily dose normalized to maternal body weight. This quantity is dimensionless and is commonly compared to a safety threshold used in clinical practice.\n\nConsider a breastfeeding dyad in which the mother is treated with the selective serotonin reuptake inhibitor (SSRI) sertraline. The following data are available:\n- Maternal daily dose: $75 \\,\\text{mg/day}$.\n- Maternal body weight: $60 \\,\\text{kg}$.\n- Steady-state sertraline concentration in milk: $0.050 \\,\\text{mg/L}$.\n- Infant daily milk intake: $600 \\,\\text{mL/day}$.\n- Infant body weight: $3.5 \\,\\text{kg}$.\n\nUsing first principles of dose normalization (dose per unit body weight) and mass balance across volumes, compute the relative infant dose (RID) as a unitless decimal. Round your answer to four significant figures. For context, a commonly cited safety threshold for RID in lactation pharmacology is $0.1$, but you must report only the RID value itself. Do not include any units in your final numeric answer.",
            "solution": "The user has provided a problem that requires the calculation of the Relative Infant Dose (RID) in the context of perinatal psychopharmacology. The first step, as per protocol, is to validate the problem statement.\n\n### Step 1: Extract Givens\n- Definition: Relative Infant Dose (RID) is the proportion of the infant’s daily dose obtained through breast milk, normalized to infant body weight, relative to the maternal daily dose normalized to maternal body weight.\n- Maternal daily dose, $D_m$: $75 \\,\\text{mg/day}$.\n- Maternal body weight, $W_m$: $60 \\,\\text{kg}$.\n- Steady-state sertraline concentration in milk, $C_{\\text{milk}}$: $0.050 \\,\\text{mg/L}$.\n- Infant daily milk intake, $V_i$: $600 \\,\\text{mL/day}$.\n- Infant body weight, $W_i$: $3.5 \\,\\text{kg}$.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is scientifically grounded in the principles of pharmacokinetics and is a standard calculation in lactation pharmacology. The concept of RID is well-established. All provided data are physically and clinically realistic. The language is objective and precise. The problem is self-contained, well-posed, and requires no external information or assumptions. The units provided are consistent, requiring only a standard conversion from milliliters to liters. The problem is deemed valid.\n\n### Step 3: Verdict and Action\nThe problem is valid. A complete, reasoned solution will be provided.\n\n### Solution\nThe Relative Infant Dose (RID) is defined as the ratio of the infant's weight-normalized daily dose to the mother's weight-normalized daily dose. Let us formalize this definition.\n\nFirst, we define the mother's weight-normalized daily dose, $D_{m, \\text{norm}}$:\n$$ D_{m, \\text{norm}} = \\frac{\\text{Maternal daily dose}}{\\text{Maternal body weight}} = \\frac{D_m}{W_m} $$\nUsing the provided values:\n$$ D_{m, \\text{norm}} = \\frac{75 \\, \\text{mg/day}}{60 \\, \\text{kg}} = 1.25 \\, \\text{mg/kg/day} $$\n\nNext, we must determine the infant's absolute daily dose, $D_i$. This is the total mass of the medication ingested by the infant per day, which is calculated by multiplying the concentration of the drug in the milk by the volume of milk the infant consumes daily.\n$$ D_i = \\text{Concentration in milk} \\times \\text{Infant milk intake} = C_{\\text{milk}} \\times V_i $$\nThe provided value for milk intake, $V_i$, is $600 \\, \\text{mL/day}$. The concentration, $C_{\\text{milk}}$, is given in units of $\\text{mg/L}$. To ensure dimensional consistency, we must convert the volume from milliliters ($\\text{mL}$) to liters ($\\text{L}$). Since $1 \\, \\text{L} = 1000 \\, \\text{mL}$:\n$$ V_i = 600 \\, \\text{mL/day} \\times \\frac{1 \\, \\text{L}}{1000 \\, \\text{mL}} = 0.600 \\, \\text{L/day} $$\nNow, we can calculate the infant's absolute daily dose, $D_i$:\n$$ D_i = (0.050 \\, \\text{mg/L}) \\times (0.600 \\, \\text{L/day}) = 0.030 \\, \\text{mg/day} $$\n\nWith the infant's absolute dose, we can find the infant's weight-normalized daily dose, $D_{i, \\text{norm}}$:\n$$ D_{i, \\text{norm}} = \\frac{\\text{Infant's absolute daily dose}}{\\text{Infant's body weight}} = \\frac{D_i}{W_i} $$\nUsing the calculated value for $D_i$ and the given infant weight, $W_i = 3.5 \\, \\text{kg}$:\n$$ D_{i, \\text{norm}} = \\frac{0.030 \\, \\text{mg/day}}{3.5 \\, \\text{kg}} \\approx 0.0085714 \\, \\text{mg/kg/day} $$\n\nFinally, the RID is the ratio of the infant's normalized dose to the mother's normalized dose:\n$$ \\text{RID} = \\frac{D_{i, \\text{norm}}}{D_{m, \\text{norm}}} $$\nWe can construct a single algebraic expression for RID by substituting the formulas for each normalized dose:\n$$ \\text{RID} = \\frac{\\frac{D_i}{W_i}}{\\frac{D_m}{W_m}} = \\frac{\\frac{C_{\\text{milk}} \\times V_i}{W_i}}{\\frac{D_m}{W_m}} = \\frac{C_{\\text{milk}} \\times V_i \\times W_m}{D_m \\times W_i} $$\nSubstituting the numerical values into this expression:\n$$ \\text{RID} = \\frac{(0.050 \\, \\text{mg/L}) \\times (0.600 \\, \\text{L/day}) \\times (60 \\, \\text{kg})}{(75 \\, \\text{mg/day}) \\times (3.5 \\, \\text{kg})} $$\nThe units cancel out, confirming that RID is a dimensionless quantity:\n$$ \\frac{(\\text{mg/L}) \\times (\\text{L/day}) \\times (\\text{kg})}{(\\text{mg/day}) \\times (\\text{kg})} = \\frac{\\text{mg} \\cdot \\text{day}^{-1} \\cdot \\text{kg}}{\\text{mg} \\cdot \\text{day}^{-1} \\cdot \\text{kg}} = 1 $$\nNow we compute the numerical value:\n$$ \\text{RID} = \\frac{0.050 \\times 0.600 \\times 60}{75 \\times 3.5} = \\frac{1.8}{262.5} $$\n$$ \\text{RID} = 0.006857142857... $$\nThe problem requires the answer to be rounded to four significant figures. The first significant figure is $6$, and the fourth is $7$. The digit following the fourth significant figure is $1$, which is less than $5$, so we do not round up.\n$$ \\text{RID} \\approx 0.006857 $$\nThis result is a unitless decimal, as required.",
            "answer": "$$ \\boxed{0.006857} $$"
        }
    ]
}